Wells initiates Pfizer at overweight, says Covid treatments are here to stay

A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020.

Dado Ruvic | Reuters

Pfizer is poised to outperform as its Covid treatments stick around and generate major revenue for the company, according to Wells Fargo.

Wells initiates Pfizer at overweight, says Covid treatments are here to stay

CVS says it expects sales to accelerate as it expands its range of health-care services

I’ve processed more than 1,000 mortgages. Here are 3 things buyers in today’s market should do before they get a mortgage

Elon Musk Warns: An “Anvil” is Coming to Commercial Real Estate

‘Commercial Real Estate Is Melting Down Fast’: Elon Musk Warns Home Prices Will Be The Next To Crash — Yet One Property Type Could Prove Resilient

SEC Sues Binance. What It Means for Bitcoin and Coinbase.

Market Update: IEX, AVGO, MDB

Comments

Leave a reply Cancel reply

More in Latest News

I’m the head of talent acquisition at Vanguard. Here are the 3 things I look for in candidates and my favorite interview question to ask.

Bill Gates Makes Billion-Dollar Bet On Heineken Just Before Budweiser Controversy, Threatening The Beer Giant’s Top Ranking

PayPal’s 80% Stock Plunge Hasn’t Soured Wall Street

I Want to Gift Money. How Much Can I Give Without Owing Taxes?

Get the daily market news.

Top News